Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks

Código QR

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks

Amanda Cheung, Aijaz Ahmed Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USACorrespondence: Amanda CheungDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite 210, Stanford, CA, 94304, USATel +1...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cheung A, Ahmed A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	nonalcoholic fatty liver disease chronic kidney disease mortality metabolic syndrome gut-liver axis gut-kidney axis liver-kidney axis Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/312ed4424b72428eabd3dfe00ffb9f7f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Gut non-bacterial microbiota contributing to alcohol-associated liver disease
por: Wenkang Gao, et al.
Publicado: (2021)

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
por: Kevin De Muynck, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Impaired Intestinal <named-content content-type="genus-species">Akkermansia muciniphila</named-content> and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice
por: Zunji Shi, et al.
Publicado: (2021)

Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition
por: K. C. Bauer, et al.
Publicado: (2020)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD
por: Norio Akuta, et al.
Publicado: (2021)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Rui Xue, et al.
Publicado: (2021)

Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics
por: Xiaomin Yuan, et al.
Publicado: (2021)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
por: Sadatsugu Sakane, et al.
Publicado: (2021)

Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
por: Motoh Iwasa, et al.
Publicado: (2021)

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
por: Azarkar G, et al.
Publicado: (2019)

Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease
por: Francesca Tinti, et al.
Publicado: (2021)

Effects of Xylooligosaccharides on Lipid Metabolism, Inflammation, and Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet
por: Fang Li, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9Summary
por: Robim M. Rodrigues, et al.
Publicado: (2022)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Potential relation between non-alcoholic fatty liver disease and glycemic and metabolic parameters in subjects without diabetes
por: H. Naguib, et al.
Publicado: (2021)

Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Ben F.J. Goudsmit, et al.
Publicado: (2021)

Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
por: Deng Y, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
por: Diaz Soto MP, et al.
Publicado: (2020)

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies
por: Marciano S, et al.
Publicado: (2019)

NAFLD Nutritional Management: Results from a Multidisciplinary Approach
por: Sara Raquel Osório Policarpo, et al.
Publicado: (2021)

Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
por: Paul Carrier, et al.
Publicado: (2021)

Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case–control study
por: Yong Xie, et al.
Publicado: (2021)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt SJ, et al.
Publicado: (2014)

Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
por: Alba Rocco, et al.
Publicado: (2021)

Bacterial membrane vesicles and phages in blood after consumption of Lacticaseibacillus rhamnosus JB-1
por: Kevin Champagne-Jorgensen, et al.
Publicado: (2021)

The Potential Utility of Prebiotics to Modulate Alzheimer’s Disease: A Review of the Evidence
por: Jea Woo Kang, et al.
Publicado: (2021)

Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients
por: Lee YJ, et al.
Publicado: (2020)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Tomomi Kogiso, et al.
Publicado: (2021)

Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study
por: Masato Shizuku, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka M, et al.
Publicado: (2015)